|
HS Code |
766831 |
| Chemical Name | Growth Hormone Releasing Peptide-6 |
| Abbreviation | GHRP-6 |
| Peptide Sequence | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 |
| Molecular Formula | C46H56N12O6 |
| Molecular Weight | 873.01 g/mol |
| Mechanism Of Action | Stimulates growth hormone secretion by binding to ghrelin receptors |
| Administration Route | Subcutaneous or intramuscular injection |
| Half Life | Approximately 20-30 minutes |
| Storage Temperature | Refrigerated at 2-8°C |
| Appearance | White lyophilized powder |
As an accredited Growth Hormone Releasing Peptide-6 (Ghrp-6) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White cardboard box labeled "GHRP-6, 5mg/vial, 10 vials," each vial is sealed, clear, with blue cap and printed lot details. |
| Shipping | Growth Hormone Releasing Peptide-6 (GHRP-6) is shipped in lyophilized powder form, securely sealed in vials to maintain stability. It is packaged with insulating materials and cold packs, if required, to protect against temperature fluctuations. Expedited delivery ensures product integrity and compliance with safety and regulatory standards for chemical shipments. |
| Storage | Growth Hormone Releasing Peptide-6 (GHRP-6) should be stored as a lyophilized powder at -20°C, protected from light and moisture. Once reconstituted, it should be refrigerated at 2-8°C and used within a specified period, typically no more than 2 weeks. Proper storage preserves its stability, potency, and effectiveness for laboratory or research use. |
|
Purity 98%: Growth Hormone Releasing Peptide-6 (Ghrp-6) with a purity of 98% is used in peptide research studies, where it ensures consistent bioactivity and reproducible experimental results. Molecular weight 873.01 Da: Growth Hormone Releasing Peptide-6 (Ghrp-6) at a molecular weight of 873.01 Da is used in pharmacological screening, where it facilitates accurate dose response modeling in vitro. Stability at 4°C: Growth Hormone Releasing Peptide-6 (Ghrp-6) with stability at 4°C is used in clinical trial sample storage, where it maintains peptide integrity over prolonged periods. Lyophilized powder form: Growth Hormone Releasing Peptide-6 (Ghrp-6) in lyophilized powder form is used in custom formulation development, where it guarantees ease of reconstitution and minimizes degradation risk. Peptide sequence H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2: Growth Hormone Releasing Peptide-6 (Ghrp-6) with the peptide sequence H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 is used in structure-activity relationship studies, where precise sequence fidelity supports accurate receptor binding assays. Endotoxin level <0.1 EU/mg: Growth Hormone Releasing Peptide-6 (Ghrp-6) with an endotoxin level below 0.1 EU/mg is used in preclinical animal experiments, where low endotoxin content reduces risk of immunogenic interference. HPLC analysis ≥99%: Growth Hormone Releasing Peptide-6 (Ghrp-6) subjected to HPLC analysis at ≥99% is used in quality control labs, where high analytical purity enhances batch-to-batch consistency evaluation. Solubility in water >20 mg/mL: Growth Hormone Releasing Peptide-6 (Ghrp-6) with water solubility greater than 20 mg/mL is used in injectable formulation research, where high solubility promotes rapid diffusion and homogenization. |
Competitive Growth Hormone Releasing Peptide-6 (Ghrp-6) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Growth Hormone Releasing Peptide-6, known as Ghrp-6, draws frequent attention from the scientific community, especially those pushing the frontiers of hormone research and biologically active compounds. As a long-standing chemical manufacturer, our experience with Ghrp-6 stretches back to the peptide's earliest adoption in mainstream endocrinological study. Every batch reflects that familiarity, and it always begins with meticulous attention to purity and consistency. In our years producing peptides, Ghrp-6 stands out for how sharply its profile matches the needs of researchers aiming for reliable, reproducible results in growth hormone stimulation experiments.
At the production level, Ghrp-6 consists of a short chain of amino acids, engineered to interact with specific ghrelin receptors and encourage the pituitary gland to release growth hormone. Precision matters here, and we start with top-quality, traceable raw amino acid substrates. Our reactors and synthesizers use controlled, stepwise solid-phase peptide synthesis, ensuring each amino acid occupies the right spot in the chain. Over the years, we have found that the smallest mistakes in timing or atmosphere lead to impure final product, which directly affects experimental outcomes. That’s why purification comes next: we drive impurity content down below demanding lab standards using repeated HPLC cycles, followed by careful lyophilization. Peptide content and chain integrity find confirmation through rigorous mass spectrometry and tandem chromatographic techniques.
Our team pays special attention to oxidation sensitivity and moisture content, both of which can impact the shelf-stability and reconstitution performance of Ghrp-6. Each container we ship is filled under nitrogen and sealed to protect that fresh, sharp-edged peptide profile researchers expect from experienced manufacturers, not casual suppliers or repackagers.
We produce Ghrp-6 most commonly in lyophilized, sterile powder form, adjusted to the research and formulation requirements that university, pharmaceutical, and biotech labs demand. Every lot gets verified for both peptide content and integrity, using analytical tools like HPLC, LC-MS, and amino acid analysis. Typical vials come in 1mg, 5mg, and 10mg configurations. It’s not only the total weight that matters, but the actual mass of functional, intact Ghrp-6. That exactitude has ripple effects downstream, especially in cell work, animal studies, or pilot formulation runs where dose accuracy translates into valid or invalid results.
A key difference between Ghrp-6 and some other peptides lies in its clean release profile and the lack of structural or functional drift between lots. We rely on decades of accumulated process control data to hit tight molecular weight and identity targets. Researchers often ask about storage and handling: based on our long-term stability tests, Ghrp-6 keeps best at -20°C, away from light and repeated thaw cycles. Strict temperature tracking during storage and transit reduces breakdown and preserves activity for its intended research use. We never ship outside controlled insulation; rushed handling leads to hydration and degradation that even minor resellers can overlook.
Peptide products have proliferated in recent years, but not all follow the same biological mechanisms. Ghrp-6 belongs to the growth hormone releasing peptide group, but users regularly compare it to Ghrp-2, ipamorelin, or sermorelin. From our perspective as a production facility, the main differences involve both structure and receptor interaction. Ghrp-6 presents a unique chain arrangement and confers stronger ghrelin receptor affinity. This yields a pronounced, predictable pulse of growth hormone in biological systems, unlike ipamorelin, which displays more selectivity and subtler hormone release over time.
From a chemical manufacturing angle, Ghrp-6’s chain composition brings specific challenges. The presence of D-amino acids and its exact terminal modifications push us to fine-tune synthesis cycles and protect the product from racemization and chain truncation. Over time, we've seen research applications for Ghrp-6 broaden into areas like metabolic modeling, inflammation studies, and tissue regeneration work, because the peptide’s interaction with non-pituitary tissues continues to interest endocrinologists and cell biologists alike. Direct comparison with classic secretagogues like Ghrh reveals that Ghrp-6 often triggers additional appetite and ghrelin-linked responses, which some labs explore for obesity or hunger signaling research.
Daily interaction with customers gives us a clear view into how folks actually handle Ghrp-6 in their workspaces. After opening, it pays to let the vial warm up slightly to room temperature—this minimizes condensation right on the powder, which can otherwise undermine both solubility and product longevity. Water for injection or sterile saline work best for reconstitution, and using a gentle swirling motion rather than violent shaking protects peptide bonds and keeps aggregates from forming. Inexperienced handlers sometimes see minor foam or clouding and worry about product integrity; we advise patience, as most lyophilized Ghrp-6 dissolves cleanly with minimal agitation, reflecting a well-executed production run.
We urge research teams to aliquot single-use portions and freeze the rest when tight experimental control is needed over multiple time points. Experience teaches that repeated freeze-thaw cycles chip away at the peptide’s potency, a reality that comes from years testing older vs. freshly prepared stocks. Wide adoption in animal studies, pituitary cell research, and in vitro signaling models shows that most labs look for minimal carrier content—our protocols avoid stabilizers or mannitol excipients unless specially requested, putting scientific control back in the hands of users.
Folks often ask us to weigh Ghrp-6 against the parade of related growth hormone peptides that cross reference lists and catalogues each year. True, Ghrp-2 and ipamorelin grab plenty of headlines for their receptor selectivity, but Ghrp-6 earns a following thanks to its broad effectiveness and pronounced, reliable hormone pulse in animal models. Manufacturing Ghrp-6 presents higher demands for handling equipment—its structure means susceptibility to certain acid-catalyzed breakdown reactions denied to simpler peptides. In our workshops, we hammer home humidity and oxidant control at all times.
One common pitfall newer labs face involves inconsistent sourcing between vendors. We routinely hear about variable growth response or inconsistent plasma peaks from research teams using non-specialists or overseas brokers. That brings headaches no amount of careful experiment setup compensates for. Long-term traceability, built through supply chain integration, stands behind every vial we produce. We give customers full transparency over lot-scale, chain sequence, and purity, which large trading intermediaries rarely provide with confidence.
Manufacturing growth peptides like Ghrp-6 involves serious responsibility—a fact that becomes obvious every time a new inquiry about off-label or clinical use lands on our desk. Strictly speaking, we supply Ghrp-6 for laboratory research only; any deviation into human or veterinary application without explicit regulatory clearance invites unnecessary risks. Our quality control regime adheres to international standards, but we always make it clear: end-use accountability stays with the buyer, and attempts to shortcut regulatory oversight can set back promising work by years.
Our batch records not only satisfy internal audits but also align with requests from university research ethics boards and regulatory investigators when Ghrp-6 findings make the leap from benchtop to preclinical or investigational trials. Decades in the industry teach respect for data integrity, honest reporting, and solid recordkeeping. Whenever a new paper comes out citing results with Ghrp-6, we scrutinize process details, purity, and dosing protocol. This emphasis on traceability keeps peer reviewers and funding agencies confident in the legitimacy of results.
No batch leaves our facility without full documentation on synthesis route, chromatograms, and mass confirmation. Still, issues sometimes arise downstream. From experience, unexpected solubility issues mostly result from overexposure to air or improper storage, not flaws in initial production. Occasionally, users misinterpret cloudy solutions or sluggish dissolution as a sign of contamination, when the true culprit is atmospheric moisture or improper solvent use. This reality leads us to respond quickly with support: we walk through spectra, double-check lot data, and guide the team through simple bench tests to restore confidence in ongoing experiments.
Feedback from repeat research teams cycles right back into process refinement. A decade ago, lyophilization runs yielded occasional differences in cake appearance; customer input drove us to innovate freeze-drying profiles and container finishes, resulting in the smoother, more uniform product researchers see today. This kind of feedback loop happens only in tightly run, vertically integrated manufacturing settings. Distributors and brokers lack the process depth or production control to make these incremental but important advances.
Responsible peptide production means more than just batch quality. As concerns over chemical waste and environmental impact grow, we've invested in efficient solvent recycling, waste stream minimization, and energy conservation. Synthesis of Ghrp-6 traditionally calls for various organic solvents, but through closed-loop recycling and catalytic cleaner systems, we have cut waste output compared to older, less sophisticated practices.
Waste acid from resin cleavage and purification gets fully neutralized, with spent resin channeled to authorized disposal partners. Each time we upgrade our reactors or chromatography columns for efficiency, trace solvent levels in waste drop, and downstream environmental costs shrink. This stewardship allows research partners fair assurance that Ghrp-6 ordered from us reflects both technical strength and a clear-eyed approach to planet health.
Ghrp-6, though simple in structure compared to some longer or cyclized peptides, serves as an unsung hero in early-stage growth hormone research. The predictability and robustness of its activity in standardized assays have underpinned countless published studies on somatotropic axis function, non-classical pituitary signaling, and ghrelin-based metabolic control. Each time a new study confirms a novel receptor interaction or secondary response, we dig into supplied methods and batch data to confirm match with our own QC records, ensuring no ambiguity in chemical identity.
Researchers return to Ghrp-6 not out of habit, but because they find their work unreproducible using inconsistent or poorly specified alternatives. Over the years, some clients remain surprised to learn how short-lived competitors enter markets with sub-par batch records or unlabeled impurities. We see first-hand how returns soar and research delays pile up when end-users try to save on up-front cost by choosing brokers who simply split and repackage generic bulk materials.
Our approach draws on decades of direct engagement with researchers, not distant sales teams or generic catalog writers. Each lot of Ghrp-6 we manufacture represents a commitment to transparency and support—details matter, process documentation matters, and straightforward communication makes all the difference when unpredictable results crop up. We treat each inquiry as a chance to learn and improve—odds are, if a lab faces a unique solubility, purity, or bioactivity question, we’ve seen it (or something close) over countless experimental runs.
Direct manufacturer support means problems get solved quickly. Shipping temperature exposures, accidental freeze-thaw events, or minor inconsistencies in appearance—all get resolved by the same team who oversaw synthesis, not middlemen reading script from upstream suppliers. As the regulatory landscape tightens and scrutiny of chemical origin increases, peace of mind comes not from paperwork alone, but from being able to speak directly with the folks who understand each technical step in Ghrp-6 production.
The scientific community’s growing appetite for next-generation peptides—those designed for even more selective receptor interaction, greater metabolic stability, or new tissue penetration profiles—drives us forward. Ghrp-6 represents a bridge between classic secretagogues and newer, more targeted molecules. As we invest in higher-throughput reactors, more sensitive purification stages, and advanced analytical verification, our teams keep pace with evolving needs. Direct communication with leading laboratories, feedback on animal model anomalies, and requests for unique chain modifications all flow into process improvement cycles.
With stricter regulatory frameworks appearing in jurisdictions worldwide, and research funding tied to transparent batch documentation, our investment in full traceability and chain-of-custody documentation pays dividends for customers at every scale. Trusted Ghrp-6 supply impacts grant success rates, publication acceptance, and ability to scale from benchtop to pilot production. Regular roundtable sessions with process engineers and QC analysts ensure we don’t lose sight of everyday lab realities, despite increased automation and scale.
Growth Hormone Releasing Peptide-6 continues to hold a special place in the modern peptide toolkit due to its clean, strong, and reliable growth hormone stimulation profile. Decades of manufacturing experience have shown us that quality control, production transparency, and direct user engagement separate trusted chemical manufacturers from the sea of newer brokers and copy-paste catalog houses. Every bottle of Ghrp-6 leaving our facility echoes real-life lessons, hands-on process improvements, and a commitment to keeping the scientific endeavor moving forward, one well-characterized batch at a time.
For us, Ghrp-6 isn’t just a product code or line item in a sales spreadsheet. It’s a material that earns its keep through years of careful production, feedback-driven refinement, and close partnership with research teams chasing answers at the edge of human knowledge. It’s a promise—not just of purity and precision, but of ongoing support and technical honesty, all the way from amino acid sourcing to the last milligram used on the benchtop.